Lamivudine, adefovir and tenofovir exhibit long-lasting anti-hepatitis B virus activity in cell culture (Q28373274)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Lamivudine, adefovir and tenofovir exhibit long-lasting anti-hepatitis B virus activity in cell culture	scientific article

Statements

instance of

scholarly article

0 references

title

Lamivudine, adefovir and tenofovir exhibit long-lasting anti-hepatitis B virus activity in cell culture (English)

0 references

main subject

tenofovir

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

lamivudine

1 reference

based on heuristic

inferred from title

author

Erik De Clercq

series ordinal

2

object named as

E De Clercq

0 references

author name string

C Ying

series ordinal

1

0 references

J Neyts

series ordinal

3

0 references

language of work or name

English

0 references

publication date

January 2000

0 references

published in

Journal of Viral Hepatitis

0 references

volume

7

0 references

issue

1

0 references

page(s)

79-83

0 references

cites work

Therapy of viral hepatitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00192.X

retrieved

21 January 2018

Treatment and prevention of chronic viral hepatitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00192.X

retrieved

21 January 2018

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00192.X

retrieved

21 January 2018

Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00192.X

retrieved

21 January 2018

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00192.X

retrieved

21 January 2018

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00192.X

retrieved

21 January 2018

Preclinical aspects of lamivudine and famciclovir against hepatitis B virus

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00192.X

retrieved

21 January 2018

Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: A pilot study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00192.X

retrieved

21 January 2018

A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00192.X

retrieved

21 January 2018

A novel selective broad-spectrum anti-DNA virus agent

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00192.X

retrieved

21 January 2018

Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00192.X

retrieved

21 January 2018

Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00192.X

retrieved

21 January 2018

Mutations in hepatitis B DNA polymerase associated with resistance to lamivudine do not confer resistance to adefovir in vitro

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00192.X

retrieved

21 January 2018

Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00192.X

retrieved

21 January 2018

Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00192.X

retrieved

21 January 2018

Identifiers

DOI

10.1046/J.1365-2893.2000.00192.X

0 references

PubMed publication ID

10718947

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28373274&oldid=2275766978"